Fizyhealth
BoomRx for GLP-1 plus peptide programs

Can BoomRx run GLP-1 and peptide protocols together?

BoomRx can serve a clinic that combines GLP-1 weight-loss treatment with peptide protocols for the same patient because its 503A, 503B, and brand partner network compounds both. The evaluation here is multi-protocol ordering: a single patient may need a GLP-1 from one compounder and peptides from another, so the platform question is whether those lines route cleanly from one cart and one checkout. BoomRx markets competitive dashboard pricing and a flat $30 cold-chain shipping rate — confirm whether patient-linked batch checkout matches your ops pattern.

Combining GLP-1s and peptides for one patient is a multi-protocol ordering problem. This page covers how these programs should evaluate BoomRx and where a pass-through platform like Fizy Health changes the math.

Compare Fizy Health vs BoomRx

Proudly Partnered With

Who this is for

Clinics layering peptides onto GLP-1 weight-loss programs.

These programs combine protocols on one patient: a GLP-1 for weight loss alongside peptides for recovery, sleep, or metabolic support, often sourced from different 503A pharmacies. The ordering challenge is keeping one patient's stack together. Three roles feel the platform most.

  • Owners

    Owners building layered programs.

    Owners differentiate by offering more than a single GLP-1 — they layer peptides into a fuller program. Their core question is whether they can see landed cost across both protocols to price a combined program, and whether ordering both stays simple.

  • Operators

    Staff ordering combined stacks.

    Operations staff build orders where one patient needs a GLP-1 and several peptides, sometimes across compounders. They need one cart that holds the whole stack and one checkout, rather than splitting a single patient's program into multiple orders.

  • Prescribers

    Providers managing two protocols.

    Prescribers manage a GLP-1 titration alongside peptide cadences for the same patient, each with its own SIG. Their priority is accurate directions and licensure handled before anything ships, so a combined program reaches the right pharmacies cleanly.

Where BoomRx fits a combined program

BoomRx's multi-pharmacy model is the right category for combined programs because a GLP-1 and a set of peptides often do not come from the same 503A pharmacy. Consolidating both protocols under one dashboard, instead of separate pharmacy portals, is the headline benefit when a single patient's program spans compounders.

What to confirm is how a single patient's multi-protocol order is handled. BoomRx does not publish detail on whether a GLP-1 from one compounder and peptides from another stay in one cart and one checkout, or whether they fragment into separate orders. And because BoomRx procurement is dashboard-first, per-item landed cost across both protocols may not be visible on each patient line before checkout — the number you need to price a combined program.

The multi-protocol pitfalls to test

Combined programs hit pitfalls around keeping a patient's stack together. Ask whether a single patient's GLP-1 and peptides can share one cart even when they route to different compounders, or whether you end up placing two orders and two payments for one program. Ask whether validation runs before payment across both protocols, since a mismatch in either line delays the whole program. And confirm recurring orders handle a combined cadence.

Fizy Health is built for patient-linked 503A clinic checkout and multi-protocol patients. A single patient's GLP-1 and peptides stay in one validated clinic cart, multi-pharmacy routing sends each line to the right compounder from one payment, per-item cost is visible across both protocols before checkout, and recurring lines can move to auto-ship. Where BoomRx publishes no detail, treat it as a demo question rather than an assumption.

Pick the platform that keeps a combined program together.

BoomRx fits if

BoomRx

You want GLP-1s and peptides sourced through one unified procurement portal.

  • You will verify that a patient's GLP-1 and peptides share one cart before committing.
  • BoomRx consolidated procurement with flat $30 cold-chain shipping matches how your team handles pharmacy issues.
  • 503B and brand-med breadth in one portal matters more than seeing landed cost across both protocols up front.
Consider Fizy Health if

Fizy Health

You want one patient's full program in one validated cart.

  • You combine GLP-1s and peptides and want both protocols in one cart and one checkout.
  • You want per-item cost visible across both protocols before checkout to price a program.
  • You want each line routed to the right compounder with validation before payment.
If you choose Fizy Health

What a combined program gets from pass-through ordering.

These are the outcomes that show up when one patient's GLP-1 and peptides stay together and cost is visible before you pay.

See all features
More use-case guides

Evaluate BoomRx for your clinic type.

See all use-case guides
FAQ

Combined program questions about BoomRx.

  • Fit

    Is BoomRx good for combined GLP-1 and peptide programs?

    BoomRx fits these programs at the category level because its 503A, 503B, and brand partner network compounds both GLP-1s and peptides. The deciding factor is whether a single patient's combined order routes cleanly from one cart when the protocols span compounders, which you should confirm directly.

  • Routing

    Can a patient's GLP-1 and peptides share one checkout?

    When a patient's program sources a GLP-1 from one compounder and peptides from another, the question is whether they stay in one cart. Fizy Health routes each line to the right partner from one validated cart and one payment, with per-line tracking.

  • Pricing

    Can I see cost across both protocols before signing?

    BoomRx shows pricing in its dashboard but procurement-first workflows may not expose resolved per-item landed cost on each patient line before checkout, so expect a sales conversation first. Fizy Health shows resolved per-item 503A cost across both protocols before checkout to price a combined program.

  • Validation

    Is a multi-protocol order validated before payment?

    BoomRx does not publicly detail pre-submit validation. Fizy Health validates SIGs, licensure, and stock across both protocols before checkout, so a mismatch in either line is fixed before payment, not after a rejection delays the whole program.

  • Recurring

    Can combined cadences be set to recur?

    GLP-1 titration and peptide cadences run on schedules. Fizy Health supports recurring auto-ship so the recurring lines in a layered program keep shipping without rebuilding each cycle.

  • Alternative

    How does Fizy Health compare for combined programs?

    Fizy Health is the same patient-linked 503A clinic checkout category but built for multi-protocol patients: one validated cart for the full program, per-line routing across compounders, visible cost across both protocols, recurring auto-ship, and in-app support tied to orders.

Sources reviewed June 2026

  • BoomRx public website (boomrx.com) and press releases (Dec 2025, Mar 2026), reviewed June 2026.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

Keep a patient's full program in one cart.

See cost across GLP-1s and peptides, route both protocols from one validated cart, and decide with real numbers. Free to start.

Start Ordering FreeFizy Health vs BoomRx